XBI logo

SPDR Series Trust - State Street SPDR S&P Biotech ETF Stock Price

ARCA:XBI Community·US$8.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

XBI Share Price Performance

US$138.67
63.16 (83.64%)
US$138.67
63.16 (83.64%)
Price US$138.67

XBI Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Weak fundamentals or lack of information.

0 Risks
0 Rewards

SPDR Series Trust - State Street SPDR S&P Biotech ETF Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$0

Other Expenses

US$0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About XBI

Founded
2006
Employees
n/a
CEO
n/a
WebsiteView website
www.ssga.com/us/en/intermediary/etfs/funds/spdr-sp-biotech-etf-xbi?fundSeoName=spdr-sp-biotech-etf-XBI

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.

Recent XBI News & Updates

No updates

Recent updates

No updates